Search Within

Weinberg Fellows

Formats
  1. Meeting Abstract (1256)
  2. Journal Article (1061)
  3. Review (108)
  4. Editorial (54)
  5. Research Letter (31)
  6. Book Section (22)
  7. Correspondence (20)
  8. Guidelines (12)
  9. Conference Paper (2)
  10. Miscellaneous (1)
Groups
  1. Department of Medicine (2470)
  2. Solid Tumor Oncology Division (1885)
  3. Hematologic Malignancies, Division of (1191)
  4. GSK Faculty (1125)
  5. Department of Pathology and Laboratory Medicine (917)
  6. Epidemiology and Biostatistics (863)

More Groups

People
  1. Michael Berger (215)
  2. Marc Ladanyi (191)
  3. Pedram Razavi (184)
  4. Michael Offin (173)
  5. David Solit (166)
  6. Maria Carlo (166)

More People

Years
  1. 2025 (152)
  2. 2024 (370)
  3. 2023 (292)
  4. 2022 (347)
  5. 2021 (307)
  6. 2020 (307)

More Years

Publications
  1. Journal of Clinical Oncology (547)
  2. Blood (248)
  3. Annals of Oncology (98)
  4. Clinical Cancer Research (95)
  5. Journal of Thoracic Oncology (82)
  6. Cancer Research (80)

More Publications

Publishers
  1. American Society of Clinical Oncology (618)
  2. Elsevier Inc. (355)
  3. American Society of Hematology (282)
  4. American Association for Cancer Research (217)
  5. Nature Publishing Group (177)
  6. Oxford University Press (147)

More Publishers

Results (2567)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Precision lineage deconvolution in mixed phenotype acute leukemia using CITE-seq derived hematopoietic stages identifies lineage dynamics associated with treatment response
    Meeting Abstract

    Dilip, D.; Galera, P.; Nemirovsky, D.; Lallo, M.; Menghrajani, K.; Derkach, A.; Levine, R. L.; Koche, R.; Xiao, W.; Glass, J.
    Blood (2023)

    Fulltext@MSK | Save
  • Targeted molecular profiling of circulating cell-free DNA in patients with advanced hepatocellular carcinoma
    Journal Article

    Cowzer, D.; White, J. B.; Chou, J. F.; Chen, P. J.; Kim, T. H.; Khalil, D. N.; El Dika, I. H.; Columna, K.; Yaqubie, A.; Light, J. S.; more...
    JCO Precision Oncology (2023)

    Fulltext@MSK | Save
  • Phase I study of paxalisib and radiotherapy for CNS disease harboring PI3K pathway mutations: Pilot analysis of circulating tumor DNA for patient eligibility confirmation and post-treatment response
    Meeting Abstract

    Imber, B.; Ravichandran, V.; Rao, P.; Casanova, H.; Friend, J.; Simpson, J.; Pike, L.; Zinovoy, M.; Mitchell, R.; Chacko, C.; more...
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • Phase I dose escalation trial combining olaparib and thoracic radiation therapy in extensive-stage small cell lung cancer
    Meeting Abstract

    Rimner, A.; Lok, B.; Gelblum, D. Y.; Kotecha, R. R.; Albrecht, F.; Shin, J. Y.; Laplant, Q.; Namakydoust, A.; Shepherd, A.; Gomez, D.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Comparable survival of treatment naive TP53 mutated acute myeloid leukemia treated with hypomethylating agent compared to hypomethylating agent plus venetoclax based therapy
    Meeting Abstract

    Badar, T.; Atallah, E. L.; Shallis, R. M.; Patel, A. A.; Correia, G. S. D. C.; Goldberg, A. D.; Saliba, A.; Bewersdorf, J. P.; Duvall, A. S.; Bradshaw, D.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Bleeding and thrombotic outcomes in adults with cancer-associated splanchnic vein thrombosis and thrombocytopenia
    Meeting Abstract

    Michael, A., Jr.; Turizo, M. J. F.; Dodge, L.; Hsu, C.; Barnum, K.; Zwicker, J. I.; Patell, R.
    Blood (2023)

    Fulltext@MSK | Save
  • What is the optimal treatment modality in molecularly defined secondary AML? A multicenter cohort study
    Meeting Abstract

    Shimony, S.; Bewersdorf, J. P.; Shallis, R. M.; Liu, Y. W.; Schaefer, E. J.; Zeidan, A. M.; Goldberg, A. D.; Stein, E. M.; Marcucci, G.; Chen, E. C.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Genomic profiles and associated survival prognosticators in Black patients with acute myeloid leukemia
    Meeting Abstract

    Stiff, A.; Nicolet, D.; Fornerod, M.; Kelly, B.; Miller, K.; Mrózek, K.; Boateng, I.; Kain, B. N.; Garfinkle, E.; Hu, E. Y.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • TP53 Y220C mutations in patients with myeloid malignancies
    Meeting Abstract

    Gener-Ricos, G.; Bewersdorf, J. P.; Loghavi, S.; Goldberg, A. D.; Famulare, C.; Issa, G. C.; Borthakur, G.; Kadia, T. M.; Carter, B. Z.; Patel, K. P.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • KOMET-008: A phase 1 study to determine the safety and tolerability of ziftomenib combinations for the treatment of KMT2A-rearranged or NPM1-mutant relapsed/refractory acute myeloid leukemia
    Meeting Abstract

    Goldberg, A. D.; Corum, D.; Ahsan, J.; Nie, K.; Kozlek, T.; Leoni, M.; Dale, S.
    Blood (2023)

    Fulltext@MSK | Save